More than four decades of graft survival in pediatric kidney transplant recipients.
Journal
Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728
Informations de publication
Date de publication:
19 Sep 2023
19 Sep 2023
Historique:
received:
19
06
2023
accepted:
29
08
2023
revised:
28
08
2023
medline:
19
9
2023
pubmed:
19
9
2023
entrez:
19
9
2023
Statut:
aheadofprint
Résumé
Early in the history of kidney transplantation, short-term graft survival was low. Yet some have had excellent long-term survival. Herein, we describe characteristics of pediatric recipients with > 40 years of graft survival currently alive with a functioning first graft. We reviewed all pediatric (age < 18 years) kidney transplants performed at the University of Minnesota between January 1, 1970, and December 31, 1979 (n = 148), to identify all recipients currently alive with a functioning first graft. Data are presented as medians with interquartile ranges (IQR) and proportions. We identified 10 recipients with > 40-year graft survival (median follow-up: 45.0 years (IQR: 43.1, 48.1)). The median age at transplant was 13.8 years (IQR: 5.1, 16.3). All recipients were white; half were male. Of the 10, 4 had glomerulonephritis, 2 had congenital anomalies of the kidney and the urinary tract, 2 had congenital nephrotic syndrome, 1 had Alport syndrome, and 1 had cystic kidney disease as kidney failure cause. Nine patients received a living-related donor transplant, and 1 patient received a deceased-donor transplant. The median estimated glomerular filtration rate at 20 years post-transplant was 79.9 (IQR: 72.3, 98.4); at 30 years, 67.7 (IQR: 63.2, 91.8); and at 40 years, 80.3 ml/min/1.73 m Pediatric kidney transplant recipients may achieve > 4 decades of graft survival. Cancer is a common complication warranting vigilant screening.
Sections du résumé
BACKGROUND
BACKGROUND
Early in the history of kidney transplantation, short-term graft survival was low. Yet some have had excellent long-term survival. Herein, we describe characteristics of pediatric recipients with > 40 years of graft survival currently alive with a functioning first graft.
METHODS
METHODS
We reviewed all pediatric (age < 18 years) kidney transplants performed at the University of Minnesota between January 1, 1970, and December 31, 1979 (n = 148), to identify all recipients currently alive with a functioning first graft. Data are presented as medians with interquartile ranges (IQR) and proportions.
RESULTS
RESULTS
We identified 10 recipients with > 40-year graft survival (median follow-up: 45.0 years (IQR: 43.1, 48.1)). The median age at transplant was 13.8 years (IQR: 5.1, 16.3). All recipients were white; half were male. Of the 10, 4 had glomerulonephritis, 2 had congenital anomalies of the kidney and the urinary tract, 2 had congenital nephrotic syndrome, 1 had Alport syndrome, and 1 had cystic kidney disease as kidney failure cause. Nine patients received a living-related donor transplant, and 1 patient received a deceased-donor transplant. The median estimated glomerular filtration rate at 20 years post-transplant was 79.9 (IQR: 72.3, 98.4); at 30 years, 67.7 (IQR: 63.2, 91.8); and at 40 years, 80.3 ml/min/1.73 m
CONCLUSION
CONCLUSIONS
Pediatric kidney transplant recipients may achieve > 4 decades of graft survival. Cancer is a common complication warranting vigilant screening.
Identifiants
pubmed: 37725164
doi: 10.1007/s00467-023-06153-z
pii: 10.1007/s00467-023-06153-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
Références
Papalois VE, Najarian JS (2001) Pediatric kidney transplantation: historic hallmarks and a personal perspective. Pediatr Transplant 5:239–245
doi: 10.1034/j.1399-3046.2001.005004239.x
pubmed: 11472601
Najarian JS, Simmons RL, Tallent MB, Kiellstrand CM, Buselmeier TJ, Vernier RL, Michael AF (1971) Renal transplantation in infants and children. Ann Surg 174:583–601
doi: 10.1097/00000658-197110000-00005
pubmed: 4329074
pmcid: 1397680
Levey AS, Stevens LA (2010) Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 55:622–627
doi: 10.1053/j.ajkd.2010.02.337
pubmed: 20338463
pmcid: 2846308
Najarian JS, So SK, Simmons RL, Fryd DS, Nevins TE, Ascher NL, Sutherland DE, Payne WD, Chavers BM, Mauer SM (1986) The outcome of 304 primary renal transplants in children (1968–1985). Ann Surg 204:246–258
doi: 10.1097/00000658-198609000-00004
pubmed: 3530152
pmcid: 1251272
Serrano OK, Matas AJ (2017) Living donor kidney allograft survival ≥ 50 years. Clin Transplant 31. https://doi.org/10.1111/ctr.12938
Spartà G, Hadaya K, Paunier L, Girardin E, Leumann E (2023) Deceased donor kidney transplanted in childhood functioning well after 52 years. Pediatr Nephrol 38:3489–3492
doi: 10.1007/s00467-023-05901-5
pubmed: 36929387
pmcid: 10465632
Starzl TE, Murase N, Demetris AJ, Trucco M, Abu-Elmagd K, Gray EA, Eghtesad B, Shapiro R, Marcos A, Fung JJ (2004) Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation 77:926–929
doi: 10.1097/01.TP.0000117780.74133.74
pubmed: 15077039
pmcid: 2977527
Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, Klinger M, Sever MS, Sørensen SS, Hadaya K, Oberbauer R, Dudley C, De Fijter JW, Yussim A, Hazzan M, Wekerle T, Berglund D, De Biase C, Pérez-Sáez MJ, Mühlfeld A, Orlando G, Clemente K, Lai Q, Pisani F, Kandus A, Baas M, Bemelman F, Ponikvar JB, Mazouz H, Stratta P, Subra JF, Villemain F, Hoitsma A, Braun L, Cantarell MC, Colak H, Courtney A, Frasca GM, Howse M, Naesens M, Reischig T, Serón D, Seyahi N, Tugmen C, Alonso Hernandez A, Beňa L, Biancone L, Cuna V, Díaz-Corte C, Dufay A, Gaasbeek A, Garnier A, Gatault P, GentilGovantes MA, Glowacki F, Gross O, de Ligny BH, Huynh-Do U, Janbon B, Del Cerro LAJ, Keller F, La Manna G, Lauzurica R, Le Monies De Sagazan H, Thaiss F, Legendre C, Martin S, Moal M-C, Noël C, Pillebout E, Piredda GB, Puga AR, Sulowicz W, Tuglular S, Prokopova M, Chesneau M, Le Moine A, Guérif P, Soulillou J-P, Abramowicz M, Giral M, Racapé J, Maggiore U, Brouard S, Abramowicz D (2016) The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients. Nephrol Dial Transplant 31:1002–1013
doi: 10.1093/ndt/gfv437
pubmed: 26763669
Massart A, Ghisdal L, Abramowicz M, Abramowicz D (2017) Operational tolerance in kidney transplantation and associated biomarkers. Clin Exp Immunol 189:138–157
doi: 10.1111/cei.12981
pubmed: 28449211
pmcid: 5508347
Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW (2012) Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney Transplant. Am J Transplant 12:1157–1167
doi: 10.1111/j.1600-6143.2012.04013.x
pubmed: 22429309
Ponticelli C, Campise MR (2021) The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation. Kidney Int 100:536–545
doi: 10.1016/j.kint.2021.04.016
pubmed: 33932457
Robinson C, Chanchlani R, Kitchlu A (2021) Malignancies after pediatric solid organ transplantation. Pediatr Nephrol 36:2279–2291
doi: 10.1007/s00467-020-04790-2
pubmed: 33057766
Wong G, Au E, Badve SV, Lim WH (2017) Breast cancer and transplantation. Am J Transplant 17:2243–2253
doi: 10.1111/ajt.14368
pubmed: 28544474
Suszynski TM, Rizzari MD, Gillingham KJ, Rheault MN, Kraszkiewicz W, Matas AJ, Chavers BM (2013) Antihypertensive pharmacotherapy and long-term outcomes in pediatric kidney transplantation. Clin Transplant 27:472–480
doi: 10.1111/ctr.12125
pubmed: 23647497
pmcid: 3674123
Hryniewiecka E, Zegarska J, Zochowska D, Samborowska E, Jazwiec R, Kosieradzki M, Nazarewski S, Dadlez M, Paczek L (2018) Cardiovascular disease in kidney transplantation and its association with blood concentrations of cyclosporine and cyclosporine metabolites. Transplant Proc 50:1850–1854
doi: 10.1016/j.transproceed.2018.03.115
pubmed: 30056914